| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | — | $0.0B | $0.0B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.5B | $0.3B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $7.61 | $7.82 | $5.15 | $4.04 | $0.92 | $0.76 | $0.66 | $0.59 |
| EPS (Diluted) | $7.43 | $7.66 | $5.07 | $3.97 | $0.90 | $0.75 | $0.66 | $0.58 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.8B | $22.9B | $20.3B | $17.4B | $14.3B | $13.9B | $11.2B | $9.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.9B | $2.0B | $2.4B | — | — | — | — | $0.6B |
| Total Liabilities | $22.1B | $20.6B | $18.4B | $15.8B | $12.9B | $12.6B | $10.1B | $8.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.7B | $2.3B | $1.9B | $1.6B | $1.4B | $1.2B | $1.1B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.3B | $0.2B | $0.2B | $0.4B | $0.3B | $0.2B | $0.2B |
| Investing Cash Flow | $-1.8B | $-2.6B | $-2.4B | $-2.8B | $-0.9B | $-1.3B | $-0.9B | $-1.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.3B | $2.1B | $3.0B | $3.1B | $-0.5B | $2.2B | $1.0B | $0.8B |